MedMiraMar 3, 20212 minProduct and Regulatory Update on MedMira’s COVID-19 Product FamilyHalifax, Nova Scotia, 03 March, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines...
MedMiraJan 29, 20212 minProgress Update on MedMira’s COVID-19 Product FamilyHalifax, Nova Scotia, 29 January, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the development of a rapid antibody test...
MedMiraNov 30, 20202 minMedMira Announces Product Update Halifax, Nova Scotia, 30 December, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its validated REVEALCOVID-19™...
MedMiraOct 7, 20202 minMedMira reports additional independent performance evaluation results of REVEALCOVID-19™Halifax, Nova Scotia, 7th of October, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the results of the latest independent...
MedMiraApr 14, 20202 minMedMira Announces Update on Development of Point-of-Care Antibody TestHalifax, Nova Scotia, 15th of April, 2020 – MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of...